Sign In
Buy TNDM
$16.25
+0.84 (+5.45%)
At Close: Jul 13, 2026
Does TNDM Stock Still Deserve a Place in Your Portfolio?
11:01am, Tuesday, 07'th Jul 2026
Tandem Diabetes Care, Inc. TNDM is well-poised to grow in the coming quarters as the rising prevalence of diabetes and increasing adoption of connected care continue to support demand for automated in
Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets
08:30am, Wednesday, 01'st Jul 2026
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--The t:slim X2™ insulin pump from Tandem Diabetes Care is now compatible with Abbott's FreeStyle Libre 3 Plus CGM sensor in five EU countries.
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026
09:00am, Tuesday, 30'th Jun 2026
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after th
Tandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026
08:30am, Tuesday, 30'th Jun 2026
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after the financial
Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
06:28pm, Monday, 08'th Jun 2026
Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Wall Street Analysts See a 56.2% Upside in Tandem Diabetes Care (TNDM): Can the Stock Really Move This High?
10:57am, Friday, 05'th Jun 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 56.2% in Tandem Diabetes Care (TNDM). While the effectiveness of this highly sought-after metric is questionabl
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
09:00am, Friday, 05'th Jun 2026
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indicati
Tandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During Pregnancy
08:30am, Friday, 05'th Jun 2026
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care receives CE mark for AID systems in Europe to include use in type 1 diabetes during pregnancy and adults with type 2 diabetes.
Reasons to Add Tandem Diabetes Stock to Your Portfolio Right Now
01:01pm, Thursday, 04'th Jun 2026
TNDM's pay-as-you-go shift, international expansion and strong liquidity support growth, while macro and reimbursement risks remain.
3 Stocks to Invest in as Broker Rating Upgrades Signal Upside
10:31am, Thursday, 04'th Jun 2026
Broker upgrades flag upside in Tandem, Dell and CNO Financial as earnings forecasts jump and analysts lift ratings over the past four weeks.
Tandem Diabetes Valuation: Is 1.1x Sales a Buy?
12:26pm, Wednesday, 03'rd Jun 2026
TNDM trades near 1.1x forward sales as it shifts to pharmacy pay-as-you-go and expands Europe, with a $21 target tied to 1.3x sales.
TNDM Stock: What to Know About Tandem's 2026 Reset
12:01pm, Tuesday, 02'nd Jun 2026
Tandem Diabetes' Q1 beat, fatter margins and positive cash flow fuel its 2026 reset as it shifts more U.S. pump starts to pay-as-you-go pharmacy.
Tandem Diabetes Care Inc (TNDM) Shares Surge 12.9% -- What GF Score of 62 Tells Investors
09:11pm, Thursday, 28'th May 2026
On May 28, 2026, Tandem Diabetes Care Inc (TNDM) shares experienced a notable rise of 12.9%, bringing the current price to $16.74. The stock has fluctuated with
Silver Economy Investing: Why the Healthcare Giants Are in Focus
04:01pm, Tuesday, 19'th May 2026
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up
09:40am, Thursday, 14'th May 2026
Tandem Diabetes beats Q1 revenue and earnings estimates as gross margin expands, but shares decline 23.6% after the results announcement.
